West Pharmaceutical Services Inc Scores High in Growth Model

West Pharmaceutical Services Inc is rated 77% in a guru strategy. This suggests a solid interest in the stock, potentially affecting its market performance positively.

Date: 03-02-2025

AI Rating: 7

Performance Overview

West Pharmaceutical Services Inc (WST) has received a strong rating of 77% under the P/B Growth Investor model, indicating favorable attributes that may lead to sustained future growth. A score above 80% typically suggests a strong interest from investors, while 90% or above indicates exceptional interest.

Key Factors Contributing to Rating

The stock has passed multiple criteria such as:

Book/Market Ratio
Return on Assets
Cash Flow from Operations to Assets
Cash Flow from Operations to Assets vs. Return on Assets
Return on Assets Variance
Sales Variance
Capital Expenditures to Assets

This indicates robust operational efficiency and strong financial health.

However, there are some criteria where the stock struggled:

Advertising to Assets (FAIL)
Research and Development to Assets (FAIL)

These failures may suggest potential weaknesses in marketing and innovation strategies, which could affect long-term growth.

Stocks: WST